- Organizations: TECLens
Pipeline
TECLens study treats first patient for noninvasive refractive vision correction
First-in-human trial is evaluating the in-office qCXL technology as an alternative to traditional refractive surgical procedures for strengthening corneal integrity.Business
TECLens raises $9.3M in funding for non-invasive refractive tech
The company's corneal CXL-based, non-incisional refractive correction procedure is designed to reshape the corneal for presbyopes and myopes.Pipeline